yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q37316553-66060D8C-02A7-4D44-BC5E-1CA60406F8FD
Q37316553-66060D8C-02A7-4D44-BC5E-1CA60406F8FD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37316553-66060D8C-02A7-4D44-BC5E-1CA60406F8FD
Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review.
P2860
Q37316553-66060D8C-02A7-4D44-BC5E-1CA60406F8FD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37316553-66060D8C-02A7-4D44-BC5E-1CA60406F8FD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
64ef154b9b8cea84f38fa4ee6f3c831c6b951105
P2860
Orlistat, a new lipase inhibitor for the management of obesity.